Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
J Clin Lab Anal. 2013 Jul;27(4):267-71. doi: 10.1002/jcla.21594.
Current routine tests for premarital screening of β-thalassemia carriers are not applicable for diagnosis of rare atypical minor β-thalassemia cases. A more specialized laboratory evaluation for them is the measurement of β/α chain synthesis ratio with the assistance of radioactive amino acids. This method is also no longer routinely accessible. Consequently it is required to establish a rapid, trouble-free, and reliable method that encompasses all the cases of β-thalassemia carriers. Therefore we have determined β/α-globin mRNA ratio by applying relative qRT-PCR in various β-thalassemia patients.
Reticulocytes RNA extraction and subsequent cDNA synthesis were performed, followed by relative qRT-PCR for α- and β-globin chain genes and β-actin gene as an endogenous reference. β/α-Globin gene ratio was then evaluated with the Pfaffl method.
The mean of β/α ratio was 0.99, 0.81, 0.69, and 0.69 for normal population, minor, intermediate, and major β-thalassemia, respectively. Approximately 6% of cases with minor thalassemia RBC index and normal HbA2 and having a decreased β/α ratio were located in the minor β-thalassemia group. The mean of β/α mRNA ratio in normal individuals and minor β-thalassemia was significantly different with all other groups (P-value < 0.05). Nevertheless, there was no such association between β/α mRNA ratio in major and intermediate β-thalassemia.
According to the significant differences achieved, no overlapping between minor β-thalassemia and normal group, capability of diagnosing atypical minor β-thalassemia, and accessibility of this technique, we can declare that this method could be suggested as a routine premarital screening test for β-thalassemia carriers.
目前用于筛查β-地中海贫血携带者的常规婚前检查不适用于诊断罕见的非典型β-地中海贫血病例。对于这些病例,更专业的实验室评估是使用放射性氨基酸测量β/α 链合成比。这种方法也不再常规使用。因此,需要建立一种快速、无故障且可靠的方法,涵盖所有β-地中海贫血携带者的情况。因此,我们通过应用相对 qRT-PCR 确定了各种β-地中海贫血患者的β/α-珠蛋白 mRNA 比值。
提取网织红细胞 RNA,随后进行 cDNA 合成,然后对α-和β-珠蛋白链基因以及β-肌动蛋白基因(作为内参)进行相对 qRT-PCR。然后使用 Pfaffl 法评估β/α-珠蛋白基因比值。
正常人群、轻度、中间型和重型β-地中海贫血患者的β/α 比值平均值分别为 0.99、0.81、0.69 和 0.69。大约 6%的 RBC 指数轻度地中海贫血、HbA2 正常且β/α 比值降低的病例位于轻度β-地中海贫血组。正常个体和轻度β-地中海贫血患者的β/α mRNA 比值平均值与其他所有组均有显著差异(P 值 < 0.05)。然而,重型和中间型β-地中海贫血患者的β/α mRNA 比值之间没有这种关联。
根据所达到的显著差异、轻度β-地中海贫血和正常组之间无重叠、诊断非典型轻度β-地中海贫血的能力以及该技术的可及性,我们可以宣布该方法可作为β-地中海贫血携带者的常规婚前筛查试验。